Molecular pathological analysis of mucinous adenocarcinomas of the stomach

Pathobiology

Volumn 71, Issue 4, 2004, Pages 201-210

  Wu, Ming ^a   Semba, Shuho ^a   Li, Dong ^a   Yokozaki, Hiroshi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

hMLH1; Microsatellite instability; Mucinous adenocarcinoma; p53; Stomach

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; KI 67 ANTIGEN; MUCIN; MUCIN 2; PROTEIN HGM; PROTEIN M GGMC 1; PROTEIN MLH1; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CELL TRANSFORMATION; COLLOID CARCINOMA; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE INSTABILITY; MOLECULAR DYNAMICS; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS; TISSUE SECTION; TUMOR CLASSIFICATION;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; CARRIER PROTEINS; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENES, P53; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUCINS; MUTATION; NEOPLASM PROTEINS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

MYCOBACTERIUM AVIUM COMPLEX (MAC);

EID: 3242758353     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078674     Document Type: Article

References (43)

1. Lauren P: The two histological main types of gastric carcinoma: Diffuse and so-called intestinal type carcinoma. An attempt at histological classification. Acta Pathol Microbiol Scand 1965;64:31-49.
2. Nakamura K, Sugano H, Takagi K: Carcinoma of the stomach in incipient phase: Its histogenesis and histological appearances. Gann 1968;59:251-258.
3. Tahara E: Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 1993;119:265-272.
4. Yokozaki H, Yasui W, Tahara E: Genetic and epigenetic changes in stomach cancer. Int Rev Cytol 2001;204:49-95.
5. Lengauer C, Kinzler KW, Vogelstein B: Genetic instabilities in human cancers. Nature 1998;396:643-649.
6. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B: Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995;268:1336-1338.
7. Souza RF, Appel R, Yin J, Wang S, Smolinski KN, Abraham JM, Zou TT, Shi YQ, Lei J, Cottrell J, Cymes K, Biden K, Simms L, Leggett B, Lynch PM, Frazier M, Powell SM, Harpaz N, Sugimura H, Young J, Meltzer SJ: Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet 1996;14:255-257.
8. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma, ed 2 (in English). Gastric Cancer 1998;1:10-24.
9. Consorti F, Lorenzotti A, Midiri G, Di Paola M: Prognostic significance of mucinous carcinoma of colon and rectum: A prospective casecontrol study. J Surg Oncol 2000;73:70-74.
10. Hara Y, Ogata Y, Okita A, Inuzuka K, Konishi J, Kanazawa M, Shirouzu K: A Clinicopathological study of mucinous carcinoma in the colon. J Jpn Surg Assoc 1998;59:2981-2985.
11. Kanemitsu Y, Kato T, Hirai T, Yasui K, Morimoto T, Shimizu Y, Kodera Y, Yamamura Y: Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum 2003;46:160-167.
12. Secco GB, Fardelli R, Campora E, Lapertosa G, Gentile R, Zoli S, Prior C: Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum. Oncology 1994;51:30-34.
13. Adachi Y, Mori M, Kido A, Shimono R, Maehara Y, Sugimachi K: A clinicopathologic study of mucinous gastric carcinoma. Cancer 1992;69:866-871.
14. Koufuji K, Takeda J, Toyonaga A, Kodama I, Aoyagi K, Yano S, Ohta J, Shirouzu K: Mucinous adenocarcinoma of the stomach - Clinicopathological studies. Kurume Med J 1996;43:289-294.
15. Hyung WJ, Noh SH, Shin DW, Yoo CH, Kim CB, Min JS, Lee KS: Clinicopathologic characteristics of mucinous gastric adenocarcinoma. Yonsei Med J 1999;40:99-106.
16. Shashidharan M, Smyrk T, Lin KM, Ternent CA, Thorson AG, Blatchford GJ, Christensen MA, Lynch HT: Histologic comparison of hereditary nonpolyposis colorectal cancer associated with MSH2 and MLH1 and colorectal cancer from the general population. Dis Colon Rectum 1999;42:722-726.
17. Kawamura H, Kondo Y, Osawa S, Nisida Y, Okada K, Isizu H, Uebayasi T, Takahasi M, Hata T: A clinicopathologic study of mucinous adenocarcinoma of the stomach. Gastric Cancer 2001;4:83-86.
18. Hiyama T, Yokozaki H, Shimamoto F, Haruma K, Yasui W, Kajiyama G, Tahara E: Frequent p53 gene mutations in serrated adenomas of the colorectum. J Pathol 1998;186:131-139.
19. Itoh N, Semba S, Ito M, Takeda H, Kawata S, Yamakawa M: Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma. Cancer 2002;94:3127-3134.
20. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-5257.
21. Pearse AG: The APUD cell concept and its implications in pathology. Pathol Annu 1974;9:27-41.
22. Alumets J, Hakanson R, Ingemansson S, Sundler F: Substance P and 5-HT in granules isolated from an intestinal argentaffin carcinoid. Histochemistry 1977;52:217-222.
23. Toh Y, Oki E, Oda S, Tomoda M, Tomisaki S, Ichiyoshi Y, Ohno S, Sugimachi K: An integrated microsatellite length analysis using an automated fluorescent DNA sequencer. Cancer Res 1996;56:2688-2691.
24. Nakashima H, Inoue H, Mori M, Ueo H, Ikeda M, Akiyoshi T: Microsatellite instability in Japanese gastric cancer. Cancer 1995;75:1503-1507.
25. Schneider BG, Bravo JC, Roa JC, Roa I, Kim MC, Lee KM, Plaisance KT Jr, McBride CM, Mera R: Microsatellite instability, prognosis and metastasis in gastric cancers from a low-risk population. Int J Cancer 2000;89:444-452.
26. Dolcetti R, Viel A, Doglioni C, Russo A, Guidoboni M, Capozzi E, Vecchiato N, Macri E, Fornasarig M, Boiocchi M: High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol 1999;154:1805-1813.
27. Gabbert HE, Muller W, Schneiders A, Meier S, Hommel G: The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma. Cancer 1995;76:720-726.
28. Danesi DT, Spano M, Fabiano A, Altavista P, Pasqualetti P, Toscano MG, Antonini F, Catalano P, Mecozzi A, Picconi A, Daffina A, Cucchiara G: Flow cytometric DNA ploidy, p53, PCNA, and c-erbB-2 protein expressions as predictors of survival in surgically resected gastric cancer patients. Cytometry 2000;42:27-34.
29. Liu XP, Tsushimi K, Tsushimi M, Kawauchi S, Oga A, Furuya T, Sasaki K: Expression of p21(WAF1/CIP1) and p53 proteins in gastric carcinoma: Its relationships with cell proliferation activity and prognosis. Cancer Lett 2001;170:183-189.
30. Saito H, Tujitani S, Ikeguchi M, Maeta M, Kaibara N: Neoangiogenesis and relationship to nuclear p53 accumulation and vascular endothelial growth factor expression in advanced gastric carcinoma. Oncology 1999;57:164-172.
31. Ogawa M, Onoda N, Maeda K, Kato Y, Nakata B, Kang SM, Sowa M, Hirakawa K: A combination analysis of p53 and p21 in gastric carcinoma as a strong indicator for prognosis. Int J Mol Med 2001;7:479-483.
32. Okuyama T, Maehara Y, Kabashima A, Takahashi I, Kakeji Y, Sugimachi K: Combined evaluation of expressions of p53 and p21 proteins as prognostic factors for patients with gastric carcinoma. Oncology 2002;63:353-361.
33. Chiaravalli AM, Furlan D, Facco C, Tibiletti MG, Dionigi A, Casati B, Albarello L, Riva C, Capella C: Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences. Virchows Arch 2001;438:39-48.
34. Fleisher AS, Esteller M, Wang S, Tamura G, Suzuki H, Yin J, Zou TT, Abraham JM, Kong D, Smolinski KN, Shi YQ, Rhyu MG, Powell SM, James SP, Wilson KT, Herman JG, Meltzer SJ: Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 1999;59:1090-1095.
35. Leung SY, Yuen ST, Chung LP, Chu KM, Chan AS, Ho JC: hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 1999;59:159-164.
36. Koseki K, Takizawa T, Koike M, Ito M, Nihei Z, Sugihara K: Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer 2000;89:724-732.
37. Tajima Y, Shimoda T, Nakanishi Y, Yokoyama N, Tanaka T, Shimizu K, Saito T, Kawamura M, Kusano M, Kumagai K: Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: Immunohistochemical analysis of 136 lesions. Oncology 2001;61:212-220.
38. Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 1996;87:159-170.
39. Endoh Y, Sakata K, Tamura G, Ohmura K, Ajioka Y, Watanabe H, Motoyama T: Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways. J Pathol 2000;191:257-263.
40. Toft NJ, Arends MJ: DNA mismatch repair and colorectal cancer. J Pathol 1998;185:123-129.
41. Goel A, Arnold CN, Niedzwiecki D, Chang DK, Ricciardiello L, Carethers JM, Dowell JM, Wasserman L, Compton C, Mayer RJ, Bertagnolli MM, Boland CR: Characterization of sporadic colon cancer by patterns of genomic instability. Cancer Res 2003;63:1608-1614.
42. Perucho M: Cancer of the microsatellite mutator phenotype. Biol Chem 1996;377:675-684.
43. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.